Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic Syndromes
Clinical trial NCT07616336 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07616336
- Sponsor
- Zhongshan Hospital (Xiamen), Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-03-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.